ArticleBMC anesthesiology2026
Crystalloid fluids choices during cardiopulmonary bypass, outcomes of acid-base and lactate levels in cardio surgery.
Article in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUltrafiltration is integral to cardiopulmonary bypass, yet the optimal replacement fluid for zero-balance ultrafiltration requires further investigation to guide clinical practice. This study aimed to compare the efficacy of Normal saline, Ringer's solution, and Ringer's lactate on lactate management, acid-base balance, and clinical outcomes.
methodsThis semi-experimental study enrolled 90 patients undergoing cardiopulmonary bypass (CPB) into three groups of 30. In Group-R, Ringer's solution was used as replacement fluid in Z-BUF. In Group-RL, Ringer's lactate and in Group-NS, Normal saline was used. Lactate and pH levels were measured at five points: before CPB and after anesthesia induction, after cardioplegia, before starting Z-BUF, after Z-BUF and after CPB.
resultsWhile there was no significant difference in baseline lactate (T1), an increasing trend was observed up to T3. At T4, immediately after Z-BUF, lactate levels were significantly higher in Group-RL (3.5 ± 1.0 mEq/L) compared to Group-R (2.3 ± 1.0 mEq/L) and Group-NS (1.9 ± 0.6 mEq/L) (p < 0.05). By T5, lactate in Group-RL decreased, showing no significant difference between groups. There were no statistically significant differences in pH between groups at any time point. However, the magnitude of pH decrease from T3 to T4 was smaller in Group-RL (7.38 ± 0.05 to 7.37 ± 0.03) compared to Group-R (7.39 ± 0.05 to 7.35 ± 0.04) and Group-NS (7.41 ± 0.07 to 7.35 ± 0.05).
conclusionWhile Ringer's lactate demonstrated favorable pH stability, its clinical superiority in preventing significant acidosis or reducing bicarbonate requirements, and the implications for postoperative nursing monitoring and fluid management protocols, require validation in larger trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.